Fulcrum Therapeutics
FULC
FULC
81 hedge funds and large institutions have $250M invested in Fulcrum Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less funds holding
Funds holding: 88 → 81 (-7)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
35% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 26
Holders
81
Holding in Top 10
1
Calls
$3.1M
Puts
$1.24M
Top Buyers
| 1 | +$6.36M | |
| 2 | +$5.29M | |
| 3 | +$4.58M | |
| 4 |
Millennium Management
New York
|
+$1.91M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.87M |
Top Sellers
| 1 | -$6.27M | |
| 2 | -$1.97M | |
| 3 | -$1.3M | |
| 4 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$1.13M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.11M |